Company intelligence / Profile preview

Olerup

Vienna, Austria

Ownership: Private
Development stage: Other

Overview

Olerup SSP offers FDA-cleared HLA typing kits using Taq-polymerase-free technology for detecting HLA Class I and Class II alleles. The product line includes options for various resolution levels and provides heterozygous ambiguity resolution through Olerup SBT (sequence-based typing) solutions[2][3].

Therapeutic areas: Immunology
Modalities: In vitro diagnostic kit
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Olerup.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olerup.

Explore the full profile